PRTN3 and interstitial lung disease: They may have a mutual impact on genes and the immune mechanism to stimulate the production of ACPA or to promote the relevant immune response in patients with RA.[14,41] This evidence is enough to show that environmental factors are crucial in the occurrence of RA-ILD.